| Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells MR Verneris, M Karami, J Baker, A Jayaswal, RS Negrin Blood 103 (8), 3065-3072, 2004 | 481 | 2004 |
| Glycogen synthase kinase 3β missplicing contributes to leukemia stem cell generation AE Abrahamsson, I Geron, J Gotlib, KHT Dao, CF Barroga, IG Newton, ... Proceedings of the National Academy of Sciences 106 (10), 3925-3929, 2009 | 289 | 2009 |
| In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity R Nishimura, J Baker, A Beilhack, R Zeiser, JA Olson, EI Sega, M Karimi, ... Blood, The Journal of the American Society of Hematology 112 (6), 2563-2574, 2008 | 249 | 2008 |
| Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study JK Chan, CA Hamilton, MK Cheung, M Karimi, J Baker, JM Gall, S Schulz, ... Clinical Cancer Research 12 (6), 1859-1867, 2006 | 199 | 2006 |
| Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells M Karimi, TM Cao, JA Baker, MR Verneris, L Soares, RS Negrin The Journal of Immunology 175 (12), 7819-7828, 2005 | 154 | 2005 |
| Measuring cytotoxicity by bioluminescence imaging outperforms the standard chromium-51 release assay MA Karimi, E Lee, MH Bachmann, AM Salicioni, EM Behrens, ... PloS one 9 (2), e89357, 2014 | 133 | 2014 |
| A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice AP McCaffrey, L Meuse, M Karimi, CH Contag, MA Kay Hepatology 38 (2), 503-508, 2003 | 119 | 2003 |
| CRK proteins selectively regulate T cell migration into inflamed tissues Y Huang, F Clarke, M Karimi, NH Roy, EK Williamson, M Okumura, ... The Journal of clinical investigation 125 (3), 1019-1032, 2015 | 53 | 2015 |
| NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT MA Karimi, JL Bryson, LP Richman, AD Fesnak, TM Leichner, A Satake, ... Blood, The Journal of the American Society of Hematology 125 (23), 3655-3663, 2015 | 48 | 2015 |
| Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells MR Verneris, A Arshi, M Edinger, M Kornacker, Y Natkunam, M Karami, ... Clinical cancer research 11 (12), 4561-4570, 2005 | 46 | 2005 |
| Targeting interleukin-2-inducible T-cell kinase (ITK) differentiates GVL and GVHD in allo-HSCT M Mammadli, W Huang, R Harris, A Sultana, Y Cheng, W Tong, J Pu, ... Frontiers in immunology 11, 593863, 2020 | 26 | 2020 |
| Targeting ITK signaling for T cell-mediated diseases S Weeks, R Harris, M Karimi Iscience 24 (8), 2021 | 17 | 2021 |
| Methods for imaging cell fates in hematopoiesis J Duda, M Karimi, RS Negrin, CH Contag Bone marrow and stem cell transplantation, 17-34, 2007 | 17 | 2007 |
| A novel bioluminescent tumor model of human renal cancer cell lines: an in vitro and in vivo characterization C Peter, JT Kielstein, R Clarke-Katzenberg, MC Adams, M Pitsiouni, ... The Journal of urology 177 (6), 2342-2346, 2007 | 15 | 2007 |
| A truncated human NKG2D splice isoform negatively regulates NKG2D-mediated function MA Karimi, OA Aguilar, B Zou, MH Bachmann, JR Carlyle, CL Baldwin, ... The Journal of Immunology 193 (6), 2764-2771, 2014 | 14 | 2014 |
| Interleukin‐2‐inducible T‐cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells M Mammadli, R Harris, L Suo, A May, T Gentile, AT Waickman, A Bah, ... Clinical and Translational Medicine 11 (12), e625, 2021 | 12 | 2021 |
| Targeting SLP76: ITK interaction separates GVHD from GVL in allo-HSCT M Mammadli, W Huang, R Harris, H Xiong, S Weeks, A May, T Gentile, ... Iscience 24 (4), 2021 | 10 | 2021 |
| Human Wnt/β-catenin regulates alloimmune signaling during allogeneic transplantation M Mammadli, R Harris, S Mahmudlu, A Verma, A May, R Dhawan, ... Cancers 13 (15), 3798, 2021 | 7 | 2021 |
| TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses R Harris, M Mammadli, S Hiner, L Suo, Q Yang, JM Sen, M Karimi Cancer Immunology, Immunotherapy 72 (6), 1581-1601, 2023 | 6 | 2023 |
| TCF-1 is required for CD4 T cell persistence functions during AlloImmunity M Mammadli, L Suo, JM Sen, M Karimi International Journal of Molecular Sciences 24 (5), 4326, 2023 | 5 | 2023 |
